Table 3.

Associations between measures of violence risk, therapeutic programme completion, recovery and overall functioning with moves on to medium secure hospital settings

	Mean score, mean (s.d.)	ANOVA, F	P
HCR-20-V3 Historical scale
Trial leave (n = 30)	17.6 (2.2)	1.057	0.210
No trial leave (n = 112)	16.9 (2.6)
HCR-20-V3 Historical scale
Trial leave (n = 30)	4.5 (2.8)	30.993	<0.001
No trial leave (n = 112)	7.0 (2.6)
HCR-20-V3 Risk (future) scale
Trial leave (n = 30)	5.9 (2.2)	22.883	<0.001
No trial leave (n = 112)	7.1 (2.4)
HCR-20-V3 Dynamic (current and future) scale
Trial leave (n = 30)	10.5 (4.8)	33.199	<0.001
No trial leave (n = 112)	14.1 (4.7)
DUNDRUM-3 programme completion scale
Trial leave (n = 30)	22.7 (3.3)	9.237	<0.001
No trial leave (n = 112)	24.4 (2.5)
DUNDRUM-4 recovery scale
Trial leave (n = 30)	22.0 (2.8)	6.863	0.001
No trial leave (n = 112)	23.8 (2.1)
Global Assessment of Functioning
Trial leave (n = 30)	60.3 (16.4)	42.899	<0.001
No trial leave (n = 112)	42.9 (20.0)

HCR-20, Historical, Clinical and Risk – 20; V3, version 3.